New, less damaging treatments are giving some patients the choice to try to preserve their ability to have children after ...

An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune checkpoint inhibitors.SCORPIO — a machine learning system developed by ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics , a leading provider of diagnostic information services, today announced the ...

A new BD will have four new operating segments: medical essentials, connected care, BioPharma systems and interventional.

There’s a new rockumentary out now about Led Zeppelin, and I have to go see it. Because I have cancer. I know, you’re thinking yet again that I’m a wacko, and while that is true, let me explain. Like ...

The vagus nerve, a complex bundle of 200,000 fibers connecting the brain to vital organs, has remained a medical enigma for ...

Gilead Sciences, Inc. GILD reported better-than-expected fourth-quarter results and provided an upbeat guidance for 2025.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

A young patient identified by the ELSA study as having early stages of Type 1 Diabetes, has received treatment to delay the ...

Zymeworks Inc., a clinical-stage biopharmaceutical company developing novel, multifunctional biotherapeutics, announced that it has entered into a securities purchase agreement with funds affiliated ...

The TriNetX-Fujitsu joint venture aligns with the growing number of Japanese medical institutions joining the TriNetX network. Researchers are already conducting novel studies using TriNetX data and ...